Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-12-08

FDA Approved: ONDANSETRON — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for ondansetron hydrochloride by Fresenius Kabi USA, LLC under an ANDA, allowing continued manufacture and distribution …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron (ondansetron)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON HYDROCHLORIDE)